AXIM BIOTECHNOLOGIES, INC.
AXIM · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Valencia Catalina: Form 4
Insider disclosure · Filed · Report period 30 Jan 2024
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2024
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q/A
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Form 4/A
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- AXIM · 05463V100 - COMMON STOCK
Company details and SEC sources
CIK 0001514946 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- AXIM on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 6191 Cornerstone Court, E, Suite 114, San Diego, CA, 92121
- Incorporated in
- NV
- Fiscal year end
- 31 December
- Former names on EDGAR
- AXIM INTERNATIONAL INC. (to 13 Aug 2014)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields